Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sight Sciences, Inc.

2.76
+0.10003.76%
Volume:118.43K
Turnover:319.77K
Market Cap:141.68M
PE:-2.69
High:2.78
Open:2.61
Low:2.51
Close:2.66
Loading ...

Sight Sciences reports Q4 EPS (23c), consensus (18c)

TIPRANKS
·
06 Mar

Sight Sciences Q4 2024 GAAP EPS $(0.23) Misses $(0.21) Estimate, Sales $19.100M Miss $19.924M Estimate

Benzinga
·
06 Mar

BRIEF-Sight Sciences Q4 Revenue USD 19.1 Million Vs. IBES Estimate USD 19.9 Million

Reuters
·
06 Mar

Sight Sciences Q4 Gross Margin 87%

THOMSON REUTERS
·
06 Mar

Sight Sciences Inc: Qtrly Shr Loss $0.23

THOMSON REUTERS
·
06 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
05 Mar

Sight Sciences Is Maintained at Neutral by Citigroup

Dow Jones
·
05 Mar

Analysts Offer Insights on Healthcare Companies: Sight Sciences (SGHT) and Teladoc (TDOC)

TIPRANKS
·
04 Mar

Sight Sciences price target lowered to $3 from $4.60 at Citi

TIPRANKS
·
04 Mar

Sight Sciences Inc expected to post a loss of 20 cents a share - Earnings Preview

Reuters
·
04 Mar

March 2025 Penny Stocks To Consider For Growth

Simply Wall St.
·
04 Mar

Will Sight Sciences, Inc. (SGHT) Report Negative Earnings Next Week? What You Should Know

Zacks
·
26 Feb

Sight Sciences to Present Comprehensive Clinical Data on the OMNI® Surgical System at the 2025 American Glaucoma Society Annual Meeting

GlobeNewswire
·
25 Feb

Sight Sciences to Report Fourth Quarter and Full Year 2024 Financial Results on March 5, 2025

GlobeNewswire
·
20 Feb

Sight Sciences (SGHT) Gets a Buy from Stifel Nicolaus

TIPRANKS
·
18 Feb

Sight Sciences to Present at Citi’s 2025 Unplugged MedTech and Life Sciences Access Day

GlobeNewswire
·
14 Feb

Sight Sciences Enhances Executive Compensation for 2025

TIPRANKS
·
29 Jan

Sight Sciences Is Maintained at Buy by UBS

Dow Jones
·
28 Jan

UBS Adjusts Price Target on Sight Sciences to $5 From $5.50, Keeps Buy Rating

MT Newswires Live
·
27 Jan

Sight Sciences price target lowered to $5 from $5.50 at UBS

TIPRANKS
·
26 Jan